Liver cirrhosis is a serious condition that happens when the liver becomes scarred and loses its ability to function properly ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

HYDERABAD: We all know the importance of taking care of our mental health and heart, but what about our livers? Fatty liver ...

formerly known as non-alcoholic fatty liver disease (NAFLD)) is the most common and rapidly increasing cause of chronic liver disease worldwide, which can lead to liver cirrhosis and liver cancer via ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects around 30% of the global population. Studies suggest ...

Selvigaltin is a small molecule commercialized by Galecto, with a leading Phase II program in Decompensated Cirrhosis.

Babu Michael was diagnosed with cirrhosis seven years ago after non-alcoholic fatty liver disease, but has now finally found ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and ...

Medical care given to a patient suffering from liver diseases is termed as liver disease treatment. Furthermore, the treatment includes use of various drugs for different types of liver conditions.